CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES

@article{Raghavan2005CYP2D6C5,
  title={CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES},
  author={Nirmala Raghavan and Donglu Zhang and Mingshe Zhu and Jianing Zeng and Lisa J. Christopher},
  journal={Drug Metabolism and Disposition},
  year={2005},
  volume={33},
  pages={203 - 208}
}
1-(2-Pyrimidinyl)-piperazine (1-PP) is an active metabolite of several psychoactive drugs including buspirone. 1-PP is also the major metabolite in the human circulation and in rat brains following oral administration of buspirone. This study was conducted to identify the enzyme responsible for the metabolic conversion of 1-PP to 5-hydroxy-1-(2-pyrimidinyl)-piperazine (HO-1-PP) in human liver microsomes (HLMs). The product HO-1-PP was quantified by a validated liquid chromatography-tandem mass… 

THE 1-(2,3-DICHLOROPHENYL)-PIPERAZINE-TO-ARIPIPRAZOLE RATIO AT STEADY STATE IN RATS AND SCHIZOPHRENIC PATIENTS

Aripiprazole metabolism includes N-dealkylation to 1-(2,3-dichlorophenyl)-piperazine which was present as a minor metabolite in serum of eight schizophrenic outpatients taking 5-15 mg/day, and it is conceivable that the metabolite contributes to the central effects of aripipazole for rats, but this is unlikely for patients taking therapeutic doses.

Cytochrome P450 reaction-phenotyping: an industrial perspective

In vitro CYP reaction-phenotyping and the integration of data are focused on and relatively simple strategies enabling the design and prioritization of follow up clinical studies are discussed.

In vitro Evaluation of 2-/3-Alkoxyphenylcarbamic Acid Esters Containing N-Arylpiperazine Moiety Against Some Nontuberculous Mycobacteria

The treatment regimens differ by species with the most important distinction being that between slow and rapid growing NTM.

Accessing Drug Metabolites via Transition-Metal Catalyzed C-H Oxidation: The Liver as Synthetic Inspiration.

This Review highlights relevant applications of chemical C-H oxidation reactions, electrochemistry and microfluidic technologies to drug templates in order to access drug metabolites, and also highlights promising reactions to this end.

Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review

Reviews of literature suggest that heterocyclic moieties and their derivatives has proven success in treating depression, and restrictions on their use have caused controversy and off-label prescription a risk, despite claims of superior efficacy.

Mania in a Case of Polypsychopharmacology: Pharmacodynamic and Pharmacokinetic Considerations Do You Believe in Magic?

  • S. Preskorn
  • Medicine, Psychology
    Journal of psychiatric practice
  • 2007
The parallel to the sorcerer’s potions are the complicated admixtures of different mood stabilizers, antipsychotics, antidepressants, and anxiolytics that clinicians sometimes resort to when treating “difficult” patients.

Die Erschließung von Wirkstoffmetaboliten durch übergangsmetallkatalysierte C‐H‐Oxidation: die Leber als Inspiration für die Synthese

Konnen klassische und moderne C-H-Oxidationsreaktionen Biotransformationen bei der Synthese von Wirkstoffmetaboliten erganzen? Wir haben versucht, bei einer Durchsicht der Literatur eine Antwort auf

References

SHOWING 1-10 OF 44 REFERENCES

Pharmacokinetic-Pharmacodynamic Modeling of Buspirone and Its Metabolite 1-(2-Pyrimidinyl)-piperazine in Rats

The results of this analysis show that buspirone and 1- PP behave as partial 5-hydroxytryptamine1A agonists in vivo and that following intravenous administration the amount of 1-PP formed is too small to contribute to the hypothermic effect.

1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.

Results, together with the fact that PmP is biochemically and pharmacologically active, suggest that the metabolite may contribute significantly to the central effects of the parent drug.

Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes.

The reaction phenotyping allows one to identify which CYP form(s) is (are) involved in the metabolism of a given drug, using a combination of data obtained with native human liver microsomes and rCYP proteins.

Metabolism of the antianxiety drug buspirone in human subjects.

The metabolism of an oral dose of the antianxiety drug buspirone labeled with 14C/15N was studied in human subjects to facilitate structural characterization of the metabolites by mass spectrometry.

Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding.

The results suggest a 2-fold effect of BSA on PHT and TLB hydroxylation: first, facilitation of the reactions via a decrease in K(m); second, a decreases in f(u) leading to a drop in reaction rate.

Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.

Results indicate that PmP formation is a pharmacologically significant process for both buspirone and MJ-13805 but it is probably less important for piribedil.

Extrahepatic Metabolism of Drugs in Humans

The metabolic profile and sites of enzymatic reactions for each drug should be determined and extrahepatic metabolism has been demonstrated for numerous drugs.

Analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)-tetralin, and of 1-(2-pyrimidinyl)-piperazine and its derivatives

It was concluded that hypothermic effects of 8-OH-DRAT, buspirone and its structure analogues were bound with preferable influence as partial agonists on the postsynaptic serotonine 1A receptors.

Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions.

  • J. M. MargolisR. Obach
  • Biology, Chemistry
    Drug metabolism and disposition: the biological fate of chemicals
  • 2003
Inhibition constants for drugs as inhibitors of microsomal drug-metabolizing enzymes, such as cytochrome P450, should be corrected for the extent of nonspecific binding to components of the in vitro matrix.